Zhejiang Wecome Pharmaceutical Company Limited (SHE:300878)

SHE:300878 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr 21, 2026	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	3,803	2,141	3,673	3,591	4,246	4,045
Market Cap Growth	41.27%	-41.72%	2.30%	-15.42%	4.95%	-
Enterprise Value	3,821	2,172	3,685	3,506	3,996	3,413
Last Close Price	26.77	14.94	24.77	24.21	28.27	26.37
PE Ratio	-	-	-	73.57	44.00	29.79
PS Ratio	28.88	6.10	7.07	6.74	6.71	6.50
PB Ratio	3.69	1.82	2.61	2.55	3.01	2.92
P/TBV Ratio	3.92	1.92	2.77	2.69	3.17	2.99
P/OCF Ratio	74.51	-	63.02	24.73	-	94.49
EV/Sales Ratio	29.02	6.19	7.09	6.58	6.31	5.48
EV/EBITDA Ratio	-	-	137.76	41.71	40.93	25.29
EV/EBIT Ratio	-	-	-	64.63	47.80	27.79
Debt / Equity Ratio	0.27	0.25	0.31	0.23	0.06	0.01
Debt / EBITDA Ratio	-	-	16.27	3.30	0.74	0.11
Net Debt / Equity Ratio	0.00	0.03	-0.10	0.11	-0.14	-0.42
Net Debt / EBITDA Ratio	-0.02	-0.37	-5.25	1.86	-2.03	-4.30
Net Debt / FCF Ratio	-0.37	-0.25	1.73	-5.54	0.83	5.30
Asset Turnover	0.08	0.19	0.26	0.30	0.38	0.50
Inventory Turnover	1.62	1.64	1.91	1.78	1.93	2.40
Quick Ratio	1.84	1.96	1.95	2.09	2.98	4.20
Current Ratio	2.34	2.57	2.36	2.50	3.74	4.67
Return on Equity (ROE)	-26.31%	-11.22%	-0.50%	3.51%	6.91%	14.25%
Return on Assets (ROA)	-7.46%	-5.44%	-0.63%	1.88%	3.15%	6.13%
Return on Invested Capital (ROIC)	-18.75%	-13.03%	-1.40%	3.06%	8.01%	15.82%
Return on Capital Employed (ROCE)	-15.70%	-11.40%	-1.20%	3.60%	5.70%	8.70%
Earnings Yield	-8.29%	-6.89%	-0.24%	1.36%	2.27%	3.36%
FCF Yield	-0.20%	-7.20%	-2.21%	-0.79%	-5.63%	-2.71%
Dividend Yield	0.51%	0.94%	1.01%	-	1.06%	2.11%
Payout Ratio	-	-	-	93.71%	83.93%	5.77%
Buyback Yield / Dilution	4.22%	4.09%	-3.96%	0.32%	-19.60%	-10.96%
Total Shareholder Return	4.75%	5.03%	-2.95%	0.32%	-18.53%	-8.86%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.